Mitsui Dirección

Dirección controles de criterios 4/4

El CEO de Mitsui es Kenichi Hori , nombrado en Apr 2021, tiene una permanencia de 3.58 años. compensación anual total es ¥610.00M, compuesta por 21.5% salario y 78.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.009% de las acciones de la empresa, por valor de $5.91M. La antigüedad media del equipo directivo y de la junta directiva es de 3.6 años y 4.9 años, respectivamente.

Información clave

Kenichi Hori

Chief Executive Officer (CEO)

JP¥610.0m

Compensación total

Porcentaje del salario del CEO	21.5%
Permanencia del CEO	3.6yrs
Participación del CEO	0.009%
Permanencia media de la dirección	3.6yrs
Promedio de permanencia en la Junta Directiva	4.9yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Kenichi Hori en comparación con los beneficios de Mitsui?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2024	n/a	n/a	JP¥1t
Jun 30 2024	n/a	n/a	JP¥1t
Mar 31 2024	JP¥610m	JP¥131m	JP¥1t
Dec 31 2023	n/a	n/a	JP¥1t
Sep 30 2023	n/a	n/a	JP¥1t
Jun 30 2023	n/a	n/a	JP¥1t
Mar 31 2023	JP¥668m	JP¥131m	JP¥1t
Dec 31 2022	n/a	n/a	JP¥1t
Sep 30 2022	n/a	n/a	JP¥1t
Jun 30 2022	n/a	n/a	JP¥998b
Mar 31 2022	JP¥338m	JP¥131m	JP¥915b
Dec 31 2021	n/a	n/a	JP¥770b
Sep 30 2021	n/a	n/a	JP¥630b
Jun 30 2021	n/a	n/a	JP¥464b
Mar 31 2021	JP¥128m	JP¥62m	JP¥335b
Dec 31 2020	n/a	n/a	JP¥255b
Sep 30 2020	n/a	n/a	JP¥267b
Jun 30 2020	n/a	n/a	JP¥329b
Mar 31 2020	JP¥129m	JP¥62m	JP¥392b

Compensación vs. Mercado: La compensación total de Kenichi($USD3.96M) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD12.67M).

Compensación vs. Ingresos: La compensación de Kenichi ha sido consistente con los resultados de la empresa en el último año.

CEO

Kenichi Hori (62 yo)

3.6yrs

Permanencia

JP¥610,000,000

Compensación

Mr. Kenichi Hori has been the President and Chief Executive Officer of Mitsui & Co., Ltd. since April 01, 2021. Mr. served as Senior Executive Managing Officer at Mitsui & Co. Ltd.since April 1, 2019 unti...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Kenichi Hori	President	3.6yrs	JP¥610.00m	0.0094% $ 5.9m
Tetsuya Shigeta	Senior Executive Managing Officer	2.6yrs	JP¥235.00m	0.0037% $ 2.4m
Yoshiaki Takemasu	Executive VP	3.6yrs	JP¥280.00m	0.0036% $ 2.3m
Tetsuya Daikoku	Senior Executive managing officer	no data	JP¥219.00m	0.0025% $ 1.6m
Makoto Sato	Senior Executive Managing Officer	2.6yrs	JP¥235.00m	0.0030% $ 1.9m
Hideaki Konishi	General Manager of Investor Relations Division	1.6yrs	sin datos	sin datos
Yuichi Takano	Executive Managing Officer & General Counsel	7.6yrs	sin datos	sin datos
Yoichiro Endo	Executive Managing Officer & COO of the Wellness Business Unit	4.6yrs	sin datos	sin datos
Sayu Ueno	Executive VP & COO of Americas Business Unit	no data	sin datos	sin datos
Yoshiki Hirabayashi	Senior Executive Managing Officer and GM of Human Resources & General Affairs Division	3.6yrs	sin datos	sin datos
Shinichi Kikuchihara	Executive Managing Officer and President & CEO of P.T. Mitsui Indonesia	2.8yrs	sin datos	sin datos
Makoto Koto	General Manager of Investment Administrative Division	8.6yrs	sin datos	sin datos

3.6yrs

Permanencia media

61.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de MITS.F se considera experimentado (3.6 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Kenichi Hori	President	6.4yrs	JP¥610.00m	0.0094% $ 5.9m
Tetsuya Shigeta	Senior Executive Managing Officer	2.4yrs	JP¥235.00m	0.0037% $ 2.4m
Yoshiaki Takemasu	Executive VP	3.4yrs	JP¥280.00m	0.0036% $ 2.3m
Makoto Sato	Senior Executive Managing Officer	2.4yrs	JP¥235.00m	0.0030% $ 1.9m
Toru Matsui	Senior Executive Managing Officer	2.4yrs	JP¥192.00m	0.0030% $ 1.9m
Takeshi Uchiyamada	Independent External Director	5.4yrs	sin datos	0.0012% $ 750.1k
Samuel Maurice Walsh	Independent External Director	7.4yrs	sin datos	0.00092% $ 579.9k
Tatsuo Yasunaga	Chairman	9.4yrs	JP¥397.00m	0.023% $ 14.5m
Masako Egawa	External Independent Director	4.4yrs	sin datos	0.00048% $ 302.6k
Haruhisa Iida	Associate Officer	7.6yrs	sin datos	sin datos
Kimitaka Mori	External Audit & Supervisory Board Member	7.4yrs	sin datos	0.00054% $ 340.4k
Soon Neo Tan	Independent External Director	1.4yrs	sin datos	sin datos

4.9yrs

Permanencia media

62yo

Promedio de edad

Junta con experiencia: La junta directiva de MITS.F se considera experimentada (4.9 años de antigüedad promedio).

Mitsui Dirección

Dirección controles de criterios 4/4

Información clave

Actualizaciones recientes de la dirección

Mitsui & Co., Ltd. Announces Change of Director

Mitsui & Co., Ltd., Annual General Meeting, Jun 19, 2024

Mitsui & Co., Ltd. Announces Management Changes

Recent updates

Akastor ASA (OB:AKAST) signed an agreement to acquire an additional 25% stake in AKOFS Offshore AS from Mitsui & Co., Ltd. (TSE:8031) for $22.5 million.

Mitsui & Co., Ltd. (TSE:8031) agreed to acquire an additional 39.2% stake in Aramark Uniform Services Japan Corporation from Vestis Corporation (NYSE:VSTS) for $37 million.

Mitsui & Co., Ltd. to Report First Half, 2025 Results on Nov 01, 2024

BP, Shell and Total Take Stake in UAE Energy Project

Mitsui & Co., Ltd. to Report Q1, 2025 Results on Aug 01, 2024

Mitsui & Co., Ltd. (TSE:8031) announces an Equity Buyback for 40,000,000 shares, representing 2.66% for ¥200,000 million.

Rohto Pharmaceutical Co.,Ltd. (TSE:4527), Mitsui & Co., Ltd. (TSE:8031) and others agreed to acquire an 86% stake in Eu Yan Sang International Ltd from Blanca Investments Pte. Ltd., Tower Capital Asia and founding family for approximately SGD 690 million.

Mitsui & Co., Ltd. to Report Fiscal Year 2024 Results on May 01, 2024

Mitsui & Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024

Mitsui & Co., Ltd. Announces Change of Director

Mitsui & Co., Ltd., Annual General Meeting, Jun 19, 2024

Mitsui & Co., Ltd. to Report Q3, 2024 Results on Feb 02, 2024

RGF Staffing B.V. entered into share sale and purchase agreement to acquire additional 30% stake in RGF Staffing Delaware, Inc. from Mitsui & Co., Ltd. (TSE:8031) for approximately 130 million.

Mitsui & Co., Ltd. (TSE:8031) announces an Equity Buyback for 12,500,000 shares, representing 0.83% for ¥50,000 million.

BEMAC Corporation and Mitsui & Co., Ltd. entered into a share purchase agreement to acquire 100% of the shares of The Switch Engineering Oy from YASKAWA Electric Corporation.

Mitsui & Co., Ltd. to Report First Half, 2024 Results on Oct 31, 2023

Mitsui & Co., Ltd. (TSE:8031) completed the acquisition of 49% stake in Solar Park Kassø Aps from European Energy A/S.

Mitsui & Co., Ltd. (TSE:8031) acquired 33.3% stake in Terreva Renewables, LLC from CIM Group, L.P.

CPC Reportedly Set for Dorado Stake

Mitsui & Co., Ltd. (TSE:8031) agreed to acquire Dermaceutical Laboratories Limited Liability Company.

Mitsui & Co., Ltd. to Report Q1, 2024 Final Results on Aug 09, 2023

Beacon Rail Metro Finance B.V. signed a share purchase agreement to acquire Mitsui Rail Capital Europe B.V. from Mitsui & Co., Ltd. (TSE:8031).

Yangzijiang Shipbuilding (Holdings) Ltd. (SGX:BS6) acquired additional 5% stake in Jiangsu Yangzi-Mitsui Shipbuilding Co. Ltd. from Mitsui & Co., Ltd. (TSE:8031) and Mitsui E&S Shipbuilding Co., Ltd for CNY 43.2 million.

Mitsui & Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024

Mitsui & Co., Ltd. (TSE:8031) executed a share purchase agreement to acquire STATS (UK) Ltd from BGF Investment Management Ltd. and others.

Mitsui & Co., Ltd. to Report Q1, 2024 Results on Aug 01, 2023

Mitsui & Co., Ltd. (TSE:8031) entered into binding agreements to acquire minority shareholder in EURICOM S.p.a. for enterprise value approximately €500 million.

Mitsui, Osaka Gas Reportedly Bid for ReNew Energy's Commercial and Industrial Project Portfolio

Mitsui & Co., Ltd. (TSE:8031) agreed to acquire remaining 50% stake in Aim Services Co., Ltd. from Aramark (NYSE:ARMK) for ¥70 billion.

Mitsui & Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2023

Mitsui & Co., Ltd. Announces Management Changes

Mitsui & Co., Ltd. (TSE:8031) agreed to acquire Sumitomo Pharma Animal Health Co., Ltd. from Sumitomo Pharma Co., Ltd. (TSE:4506).

Mitsui & Co., Ltd. to Report Nine Months, 2023 Results on Feb 03, 2023

CFW Partners, L.P, Mitsui & Co., Ltd. (TSE:8031), Fuyo General Lease Co., Ltd. (TSE:8424) and JA Mitsui Leasing, Ltd. submitted a non-binding proposal to acquire remaining 2.1% stake in Willis Lease Finance Corporation (NasdaqGM:WLFC) for $29.3 million.

ACTIS GP LLP completed the acquisition of 40% share in MT Falcon Holdings Company S.A.P.I. de C.V. from Mitsui & Co., Ltd.

Woodside Reportedly Weighs Up Options for Scarborough

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad